MétaCan
Menu
Back to cohort

Ubisol‐Q halts the progression of parkinsonian neurodegeneration in rodent models of Parkinson's disease

2013· article· en· W847151642 on OpenAlexaff
Shelley B. Weinstock, Jagdeep K. Sandhu, Marianna Sikorska, Siyaram Pandey, Jerome Cohen, Patricia Lanthier, Harvey Miller, Melissa Beyer, Carolyn Sodja, Katie Facecchia, Krithika Muthukumaran, Alyson J. Laframboise, Jessica Smith, Kate Harrison, Daniel Lopatin, Corrine Keshen

Bibliographic record

VenueThe FASEB Journal · 2013
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCoenzyme Q10 studies and effects
Canadian institutionsUniversity of Windsor
Fundersnot available
KeywordsCoenzyme Q10DopamineParkinson's diseaseNeuroprotectionPharmacologyMedicineMPTPOxidative stressBioavailabilityNeurodegenerationLevodopaDiseaseDopaminergicInternal medicine

Abstract

fetched live from OpenAlex

Coenzyme Q10 is a candidate for neuroprotection in Parkinson's disease (PD), in which both energy failure and oxidative stress are responsible for its progressive nature. The low therapeutic efficacy of CoQ10 in clinical trials of PD may be due to its insolubility in aqueous media, poor bioavailability and penetration into the brain. We have developed a technology to solubilize CoQ10 in water (Ubisol‐Q) in order to increase its therapeutic potential. Oral administration of Ubisol‐Q, containing PTS TM and CoQ10, elevated plasma and brain levels of both CoQ10 and vitamin E, in rats and mice. A prophylactic application of Ubisol‐Q (48 mg/kg/day or 6 mg/kg/day) in rodent models of PD (MPTP and paraquat) revealed a near complete protection of dopamine neurons. A therapeutic application of Ubisol‐Q, started immediately after the initiation of neuronal injury, protected dopamine neurons and preserved dopamine nerve terminals in both models of PD. Ubisol‐Q also resulted in a marked improvement in motor function of mice and rats performing on a beam walk test. The results of these pre‐clinical studies are highly encouraging and suggest that Ubisol‐Q, at lower doses than other CoQ10 products, has improved bioavailability and superior therapeutic efficacy and could be used as an adjuvant therapy in the management of PD. Ubisol‐Q is GRAS and will be tested clinically. Funding by MJFF and Zymes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.129
Threshold uncertainty score0.196

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.011
GPT teacher head0.239
Teacher spread0.228 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2013
Admission routes1
Has abstractyes

Explore more

Same venueThe FASEB JournalSame topicCoenzyme Q10 studies and effectsFrench-language works237,207